GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB: LFVN), formerly Lifeline Therapeutics, Inc., maker of Protandim®, today announced results for its third quarter ended March 31, 2007. For the three months ended March 31, 2007, the Company recorded net revenues of $1.0 million and a loss of $(0.6 million), or $(0.03) per share. For the three months ended December 31, 2006, the Company recorded net revenues of $1.1 million and a loss of $(1.8 million), or $(0.08) per share. For the three months ended March 31, 2006, the Company recorded net revenues of $1.4 million and a loss of $(0.7 million), or $(0.03) per share.
